Introduction: Paraffin injections for breast augmentation once a popular form of mammoplasty are now considered obsolete. It had been abandoned by clinicians because of its associated serious complications. The practice is however still available and is being practiced by nonmedically qualified people. Paraffin injection results in the formation of multiple foreign-body granulomas known as breast paraffinoma. The clinical features of breast paraffinoma can mimic and be mistaken for breast carcinoma or inflammatory breast carcinoma. The use of fine-needle aspiration cytology (FNAC) in the evaluation of patients with breast paraffinoma has not been fully evaluated. Methods: Retrospective review was performed on 30 patients who presented with breast paraffinoma between June 1, 2010, and June 30, 2020, who also had FNAC as part of their breast lump evaluation. Results: FNAC of 73.3% patients showed multinucleated giant cells and macrophages or histiocytes containing engulfed clear, empty intracytoplasmic vacuoles of varying sizes. In 13.3% of the patients, macrophages or histiocytes with engulfed clear intracytoplasmic vacuoles of varying sizes were seen. In 6.7% of patients, multinucleated giant cells containing engulfed vacuoles of varying sizes were seen, and in 6.7% of patients, hypocellular smears with large amount of clear spaces were seen. Oily droplets were seen in the background of all the smears, and there were no malignant cells seen. These features were compatible with breast paraffinoma. Conclusion: Most patients with breast paraffinoma can be managed conservatively and they do not require further treatment; FNAC with its characteristic features can provide the reliable diagnosis of breast paraffinoma and therefore sparing these patients from more invasive diagnostic procedures.

1.
Ho
WS
,
Chan
AC
,
Law
BK
.
Management of paraffinoma of the breast: 10 years’ experience
.
Br J Plast Surg
.
2001
;
54
(
3
):
232
4
. .
2.
Erguvan-Dogan
B
,
Yang
WT
.
Direct injection of paraffin into the breast: mammographic, sonographic, and MRI features of early complications
.
AJR Am J Roentgenol
.
2006
;
186
(
3
):
888
94
. .
3.
Yu
YH
,
Wei
W
,
Liu
JL
.
Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis
.
BMC Cancer
.
2012
;
12
(
12
):
41
. .
4.
Kanchanabat
B
,
Kanchanapitak
P
,
Thanapongsathorn
W
,
Manomaiphiboon
A
.
Fine-needle aspiration cytology for diagnosis and management of palpable breast mass
.
Aust N Z J Surg
.
2000
;
70
(
11
):
791
4
. .
5.
Chandanwale
SS
,
Gupta
K
,
Dharwadkar
AA
,
Pal
S
,
Buch
AC
,
Mishra
N
.
Pattern of palpable breast lesions on fine needle aspiration: a retrospective analysis of 902 cases
.
J Midlife Health
.
2014
;
5
(
4
):
186
91
. .
6.
Khong
PL
,
Ho
LW
,
Chan
JH
,
Leong
LL
.
MR imaging of breast paraffinomas
.
AJR Am J Roentgenol
.
1999
;
173
(
4
):
929
. .
7.
Alagaratnam
TT
,
Ng
WF
.
Paraffinomas of the breast: an oriental curiosity
.
Aust N Z J Surg
.
1996
;
66
(
3
):
138
. .
8.
Gersuny
R
.
Harte und weiche paraffin prosthesen
.
Zentralblait fur Chirurgie
.
1903
;
30
:
1
.
9.
Di Benedetto
G
,
Pierangeli
M
,
Scalise
A
,
Bertani
A
.
Paraffin oil injection in the body: an obsolete and destructive procedure
.
Ann Plast Surg
.
2002
;
49
(
4
):
391
. .
10.
Peters
W
,
Fornasier
V
.
Complications from injectable materials used for breast augmentation
.
Can J Plast Surg
.
2009
;
17
(
3
):
89
96
. .
11.
Raven
RW
.
Paraffinoma of the breast
.
Clin Oncol
.
1981
;
7
(
2
):
157
61
.
12.
Beggs
FD
,
Loosemore
T
,
Knowles
S
,
Kark
AE
.
Oleogranuloma of the breast simulating carcinoma
.
J R Soc Med
.
1985
;
78
(
6
):
493
4
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.